Chong Kun Dang Pharmaceutical Corp. - Company Profile
Powered by 
All the data and insights you need on Chong Kun Dang Pharmaceutical Corp. in one report.
$295
- Save hours of research time and resources with
our up-to-date Chong Kun Dang Pharmaceutical Corp. Strategy Report
- Understand Chong Kun Dang Pharmaceutical Corp. position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Chong Kun Dang Pharmaceutical Corp.’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 20 May 2022 | Encell to Raise Funds through Private Placement | Equity Offering |
Chong Kun Dang Pharmaceutical Corporation
|
Encell Co Ltd
|
| 20 May 2022 | Chong Kun Dang Pharma to Enter into Research Agreement with Encell | Partnership | - |
Chong Kun Dang Pharmaceutical Corporation
Encell Co Ltd
|
| 07 Jul 2021 | Chong Kun Dang Holdings Corp Enters Phase I Clinical Trial Agreement with Dt&CRO Co Ltd for atorvastatin calcium (GDCT0425682) | Contract Service Agreement |
Chong Kun Dang Pharmaceutical Corporation
|
Dt&CRO Co Ltd
|
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer